INDSWFTLAB — IND Swift Laboratories Balance Sheet
0.000.00%
- IN₹7.45bn
- IN₹3.04bn
- IN₹5.62bn
- 48
- 83
- 60
- 74
Annual balance sheet for IND Swift Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 556 | 604 | 350 | 362 | 780 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,944 | 5,648 | 6,705 | 2,137 | 2,572 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9,442 | 10,753 | 11,645 | 6,611 | 8,653 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,481 | 6,368 | 5,927 | 53.6 | 2,601 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 18,184 | 18,008 | 18,241 | 11,651 | 14,383 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,145 | 3,345 | 3,711 | 2,213 | 2,206 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 12,149 | 11,998 | 11,421 | 2,336 | 2,653 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 6,035 | 6,010 | 6,819 | 9,315 | 11,730 |
| Total Liabilities & Shareholders' Equity | 18,184 | 18,008 | 18,241 | 11,651 | 14,383 |
| Total Common Shares Outstanding |